Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance
ACS Nano · 2026
DOI: 10.1021/acsnano.5c19913 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Shangui Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation o…. Hauptthemen laut MEDLINE: Immunotherapy, Nanoparticles, Triple Negative Breast Neoplasms, Endoplasmic Reticulum. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Program for Excellent Sci-tech Innovation Teams of Universities in Anhui Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of…
- National Glycoengineering Research Center, Shandong University, Qingdao, Shandong 266237, China.
- School of Pharmacy, Wannan Medical College, Wuhu 241002, China.
- State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237 China.
- NMPA Key Laboratory for Quality Research and Evaluation of Carbohydrate-Based Medicine, Shandong University, Qingdao 266237, China.
- Shandong Freda Pharmaceutical Group Co. Ltd., Jinan 250101, China.
ORCID-Profile: Yi Hao, Hailong Wang, Haining Tan, Guangxi Zhai
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Program for Excellent Sci-tech Innovation Teams of Universities in Anhui Province
- State Key Laboratory of Microbial Technology
- Shandong Provincial Program of Taishan Industrial Experts
- National Science and Technology Major Special Project- Major New Drug Creation
Zitieren
APA
Liu, S., Zhang, C., Feng, Q., Ji, J., Xie, Y., Hao, Y., Wang, H., Tan, H., & Zhai, G. (2026). Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance. ACS Nano. https://doi.org/10.1021/acsnano.5c19913
Vancouver
Liu S, Zhang C, Feng Q, Ji J, Xie Y, Hao Y, et al. Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance. ACS Nano. 2026. doi:10.1021/acsnano.5c19913
BibTeX
@article{Liu2026,
author = {Liu, Shangui and Zhang, Cheng and Feng, Qixiang and Ji, Jianbo and Xie, Yuewu and Hao, Yi and Wang, Hailong and Tan, Haining and Zhai, Guangxi},
title = {Endoplasmic Reticulum-Targeted Biomimetic Nanoparticles Potentiate the Immunotherapy of Triple-Negative Breast Cancer by Improving Immunogenicity and Eliminating Immune Resistance},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.5c19913}
}
EUVIMED